Megureit Israel Ltd (TLV:MGRT)

Achilles Therapeutics Revenue

Megureit Israel had revenue of 18.60M ILS in the quarter ending March 31, 2025, with 17.08% growth. This brings the company's revenue in the last twelve months to 71.00M, up 18.41% year-over-year. In the year 2024, Megureit Israel had annual revenue of 68.29M with 18.68% growth.

• Revenue (ttm): 71.00M
• Revenue Growth: +18.41%
• P/S Ratio: 17.24
• Revenue / Employee: 5.07M
• Employees: 14
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	68.29M	10.75M	18.68%
Dec 31, 2023	57.54M	10.54M	22.44%
Dec 31, 2022	46.99M	14.66M	45.34%
Dec 31, 2021	32.33M	12.38M	62.03%
Dec 31, 2020	19.96M	6.02M	43.23%